227 related articles for article (PubMed ID: 23801704)
1. JAMA relaxes requirements on industry sponsored studies.
McCarthy M
BMJ; 2013 Jun; 346():f4121. PubMed ID: 23801704
[No Abstract] [Full Text] [Related]
2. An editor's considerations in publishing industry-sponsored studies.
Droller MJ
Urol Oncol; 2015 Mar; 33(3):149-54. PubMed ID: 25575712
[TBL] [Abstract][Full Text] [Related]
3. More on JAMA's policy on industry sponsored studies.
Rothman KJ; Evans S
BMJ; 2006 Feb; 332(7539):489. PubMed ID: 16497774
[No Abstract] [Full Text] [Related]
4. Independence, governance, and trust: redefining the relationship between JAMA and the AMA.
Davies HT; Rennie D
JAMA; 1999 Jun 23-30; 281(24):2344-6. PubMed ID: 10386562
[No Abstract] [Full Text] [Related]
5. On editorial freedom: implications of the JAMA affair.
McKee M; Alvarez-Dardet C
Int J Health Serv; 1999; 29(4):901-4. PubMed ID: 10615581
[No Abstract] [Full Text] [Related]
6. To integrity and beyond.
Moyer VA; First LR
Pediatrics; 2011 Apr; 127(4):776-8. PubMed ID: 21460100
[No Abstract] [Full Text] [Related]
7. Regulation of clinical research sponsored by pharmaceutical companies: a proposal.
Sotelo J
PLoS Med; 2006 Jul; 3(7):e306. PubMed ID: 16805651
[TBL] [Abstract][Full Text] [Related]
8. Note from the editor.
Freedman R
Am J Psychiatry; 2010 Nov; 167(11):1407. PubMed ID: 21041255
[No Abstract] [Full Text] [Related]
9. Trial registration: a great idea switches from ignored to irresistible.
Rennie D
JAMA; 2004 Sep; 292(11):1359-62. PubMed ID: 15355937
[No Abstract] [Full Text] [Related]
10. Full-disclosure in industry-sponsored laboratory medicine research studies: statement by the Consortium of Laboratory Medicine Journal Editors.
Rifai N; Plebani M; Wu A; Brugnara C; Delvin E; Lamb EJ; Ness PM; Wick MR; Berg JP
Scand J Clin Lab Invest; 2011 May; 71(3):177-8. PubMed ID: 21174565
[No Abstract] [Full Text] [Related]
11. Open arms for open access: Toxicological Sciences joins "Oxford Open".
Lehman-McKeeman L; Andrews S
Toxicol Sci; 2007 Dec; 100(2):317. PubMed ID: 18003599
[No Abstract] [Full Text] [Related]
12. JAMA and editorial independence.
Arch Dermatol; 1999 Mar; 135(3):323-4. PubMed ID: 10086454
[No Abstract] [Full Text] [Related]
13. Update of the editorial governance plan for JAMA.
DeAngelis CD; Maves MD
JAMA; 2004 Jan; 291(1):109. PubMed ID: 16802452
[No Abstract] [Full Text] [Related]
14. JAMA should change its policy on investigating competing interests, AMA says.
Tanne JH
BMJ; 2009 Jul; 339():b2936. PubMed ID: 19622555
[No Abstract] [Full Text] [Related]
15. Scientific publishing. Echoing other cases, NEJM says Vioxx Safety data withheld.
Couzin J
Science; 2005 Dec; 310(5755):1755. PubMed ID: 16357236
[No Abstract] [Full Text] [Related]
16. [A Nordic round-table conference on the medical journals: to keep the quality and reliability is the most important issue].
Ramel B
Lakartidningen; 2004 Jun; 101(23):2023-5. PubMed ID: 15232841
[No Abstract] [Full Text] [Related]
17. The Journal's policy regarding release of information to the public.
Fontanarosa PB; Flanagin A; DeAngelis CD
JAMA; 2000 Dec; 284(22):2929-31. PubMed ID: 11147991
[No Abstract] [Full Text] [Related]
18. On editorial freedom: implications of the JAMA affair.
Mckee M; Alvarez-Dardet C
J Epidemiol Community Health; 1999 Apr; 53(4):194. PubMed ID: 10396542
[No Abstract] [Full Text] [Related]
19. Human genomes, public and private.
Nature; 2001 Feb; 409(6822):745. PubMed ID: 11236960
[No Abstract] [Full Text] [Related]
20. JAMA Ophthalmology: it's not just a new name.
Bressler NM
JAMA Ophthalmol; 2013 Jul; 131(7):839. PubMed ID: 23846200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
